Aurobindo Pharma Ltd

NSE :AUROPHARMA   BSE :524804  Sector : Pharmaceuticals
Buy, Sell or Hold AUROPHARMA? Ask The Analyst

BSE


prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE


prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

07 May
1124.35
(-3.34%)
06 May
1163.20
(1.00%)
03 May
1151.65
(-0.41%)
02 May
1156.35
(0.25%)
30 Apr
1153.50
(0.15%)
29 Apr
1151.80
(1.81%)
26 Apr
1131.30
(2.53%)
25 Apr
1103.40
(1.78%)
24 Apr
1084.05
(-0.84%)
23 Apr
1093.25
(1.58%)
22 Apr
1076.25
(-0.99%)
19 Apr
1087.05
(-2.46%)
18 Apr
1114.50
(0.31%)
16 Apr
1111.10
(2.38%)
15 Apr
1085.30
(-0.29%)
12 Apr
1088.45
(-1.82%)
10 Apr
1108.65
(-2.06%)
09 Apr
1131.95
(1.04%)
08 Apr
1120.25
(-0.31%)
05 Apr
1123.70
(0.01%)
04 Apr
1123.60
(-1.24%)


Technical Analysis

Short Term Investors

Bullish

Medium Term Investors

Very Bullish

Long Term Investors

Very Bullish

Moving Averages

5 DMA
Bearish

1149.35


10 DMA
Bearish

1130.99


20 DMA
Bullish

1117.78


50 DMA
Bullish

1078.21


100 DMA
Bullish

1076.92


200 DMA
Bullish

983.38



Intraday Support and Resistance
(Based on Pivot Points) |

Updated On May 07, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1236.76 1203.38 1144.4 - -
R2 1203.38 1175.53 1137.72 1201.85 -
R1 1163.86 1158.33 1131.03 1160.8 1183.63
P 1130.48 1130.48 1130.48 1128.95 1140.36
S1 1090.96 1102.63 1117.67 1087.9 1110.73
S2 1057.58 1085.43 1110.99 1056.05 -
S3 1018.06 1057.58 1104.3 - -

Key Metrics

EPS

33.56

P/E

33.51

P/B

3.53

Dividend Yield

0.67%

Market Cap

65,880 Cr.

Face Value

1

Book Value

318.55

ROE

7.5%

EBITDA Growth

1,760.24 Cr.

Debt/Equity

0.16

Shareholding Pattern

  51.83% Total Promoter Holding
17.83% Mutual Fund Holdings
18.02% FIIs
6.87% Non Institution
5.03% Insurance Companies
0% Custodians
0.42% Other Parties

Shareholding History


Quarterly Result (Figures in Rs. Crores)


Aurobindo Pharma Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 6499.78 6607.87 6966.85 7407.3 7514.3
PROFIT 491.26 506.27 611.26 757.18 936.29
EPS 8.38 8.64 9.74 12.83 16.04

Aurobindo Pharma Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 2438.92 2686.19 2503.65 2771.93 3023.16
PROFIT 322.94 644.8 318 379.65 623.78
EPS 5.1 10.22 5.74 7.1 10.65

Profit & Loss (Figures in Rs. Crores)


Aurobindo Pharma Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 8223.35 12546.71 14092.78 15339.65 17050.67 20397.12 23392.24 29135.18 23075.19 25555.65
PROFIT 1175.09 1587.14 2028.78 2306.24 2423.17 2430.63 2864.68 3410.14 2757.17 1919.7
EPS 19.8 26.48 34.58 38.88 41.35 40.36 48.54 91.04 45.18 32.9

Aurobindo Pharma Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 7221.26 8321.41 9496.13 9711.68 10684.73 12746.91 13998.23 16410.55 11912.62 13692.04
PROFIT 1173.5 1518.29 1627.51 1720.3 1812.82 1537.74 1878.78 3113.04 1535.98 1220.43
EPS 19.85 25.54 27.8 28.73 30.94 26.11 32.03 53.13 24.83 21

Balance Sheet (Figures in Rs. Crores)

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 58.5958.5958.5958.5958.5958.5958.5958.5229.229.15
Reserves Total 26,781.2624,517.3921,871.2816,766.0813,832.1911,621.839,313.327,228.785,126.713,721
Total Shareholders Funds26,839.8524,575.9821,929.8716,824.6713,890.7811,680.429,371.917,287.35,155.913,750.15
Minority Interest12-1.93-0.880.141.591.822.082.5525.8225.67
Secured Loans 2,557.37543.691,053.551,314.971,661.87419.18640.82,285.152,081.942,606.44
Unsecured Loans 2,728.842,307.584,285.534,511.415,304.894,350.752,723.342,755.922,369.131,162.7
Total Debt5,286.212,851.275,339.085,826.386,966.764,769.933,364.145,041.074,451.073,769.14
Other Liabilities214.26212.91250.71162.1980.1666.4339.1323.3624.359.18
Total Liabilities32,352.3227,638.2327,518.7822,813.3820,939.2916,518.612,777.2612,354.289,657.157,554.14
APPLICATION OF FUNDS :
Gross Block 18,143.2315,524.5513,613.3312,441.2610,497.627,894.785,635.494,569.835,446.134,182.96
Less: Accumulated Depreciation7,119.544,992.464,239.753,044.792,022.771,374.1801.71390.141,740.491,461.29
Net Block11,023.6910,532.099,373.589,396.478,474.856,520.684,833.784,179.693,705.642,721.67
Capital Work in Progress5,390.013,747.23,061.531,985.921,668.461,583.041,458.08848.14419.63309.72
Investments 542.74997.15591.01554.71360.22311.54245.87122.9619.7919.79
Inventories 8,516.117,559.089,041.187,699.877,245.65,858.414,330.544,056.143,611.32,367.54
Sundry Debtors 4,466.384,012.263,503.284,315.163,413.783,080.22,765.334,606.683,539.172,636.57
Cash and Bank Balance6,084.24,190.015,474.282,842.151,957.181,262.25513.48800.26469.11178.58
Loans and Advances 2,332.861,987.721,659.591,555.312,715.721,977.281,596.81831.25659.57448.46
Total Current Assets21,399.5517,749.0719,678.3316,412.4915,332.2812,178.149,206.1610,294.338,279.155,631.15
Current Liabilities 6,735.935,643.945,378.375,310.954,849.094,052.933,161.53,409.032,828.561,603.66
Provisions 417.01233.82396.89511.72384.67294.23261.36132.93218.24126.6
Total Current Liabilities & Provisions7,152.945,877.765,775.265,822.675,233.764,347.163,422.863,541.963,046.81,730.26
Net Current Assets14,246.6111,871.3113,903.0710,589.8210,098.527,830.985,783.36,752.375,232.353,900.89
Deferred Tax Assets768.88429.74600.91163.2183.29539.17501.82227.3733.318.61
Deferred Tax Liability481552.11722.79291.69281.31615.65383.3645.05239.08223.98
Net Deferred Tax287.88-122.37-121.88-128.49-98.02-76.48118.46182.32-205.78-205.37
Other Assets861.39612.85711.47414.95435.26348.84337.77268.8485.52807.44
Total Assets32,352.3227,638.2327,518.7822,813.3820,939.2916,518.612,777.2612,354.289,657.157,554.14
Contingent Liabilities158.53157.74140.83145.98133.71211.79196.97177.11195.38151.36
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 58.5958.5958.5958.5958.5958.5958.5958.5229.229.15
Reserves Total 17,855.5817,058.7515,866.0212,993.9111,292.039,923.998,377.596,807.335,330.343,983.24
Total Shareholders Funds17,914.1717,117.3415,924.6113,052.511,350.629,982.588,436.186,865.855,359.544,012.39
Secured Loans 1,922.78288.75841.51,314.361,594.43376.19498.651,002.711,884.012,070.06
Unsecured Loans 2,280.381,606.143,200.462,427.12,925.373,342.812,555.263,162.721,400.72855.1
Total Debt4,203.161,894.894,041.963,741.464,519.83,7193,053.914,165.433,284.732,925.16
Other Liabilities87.315.03042.6822.6433.620.8721.2622.658.3
Total Liabilities22,204.6419,017.2619,966.5716,836.6415,893.0613,735.1811,510.9611,052.548,666.926,945.85
APPLICATION OF FUNDS :
Gross Block 6,214.725,724.96,688.96,180.915,446.154,292.183,758.182,830.783,507.543,008.82
Less : Accumulated Depreciation 2,527.222,139.072,216.831,763.111,296.45899.21546.56262.651,317.531,070.88
Net Block 3,687.53,585.834,472.074,417.84,149.73,392.973,211.622,568.132,190.011,937.94
Capital Work in Progress239.09225.15734.89814.85789.011,143.98906.98742.14227.19203.89
Investments 8,221.786,584.365,009.932,527.412,339.061,967.51,681.951,183.351,012.75872.62
Inventories 4,125.263,356.184,841.384,359.573,971.263,409.232,433.622,431.62,145.051,711.81
Sundry Debtors 4,560.263,973.245,928.015,7855,232.074,468.233,773.634,380.973,708.942,970.12
Cash and Bank Balance132.1450.78386.1886.1675.77245.933.64330.8111.139.72
Loans and Advances 905.972,454.91,051.41,057.551,129.22857.82662.44631.1483.32389.5
Total Current Assets9,723.639,835.112,206.9711,288.2810,408.328,981.186,903.337,774.486,348.445,081.15
Current Liabilities 2,391.012,243.32,539.032,526.662,120.151,960.641,450.461,456.071,262.61,318.25
Provisions 122.09103.36250.01115.2796.5174.5461.556.9586.02106.18
Total Current Liabilities & Provisions2,513.12,346.662,789.042,641.932,216.662,035.181,511.961,513.021,348.621,424.43
Net Current Assets7,210.537,488.449,417.938,646.358,191.666,9465,391.376,261.464,999.823,656.72
Deferred Tax Assets55.2443.8268.61411.92439.87382.06333.52267.9728.5518.56
Deferred Tax Liability271.15280.85501.99496.96470.87405.54333.44261.11238.89223.81
Net Deferred Tax-215.91-237.03-433.38-85.04-31-23.480.086.86-210.34-205.25
Other Assets3,061.651,370.51765.13515.27454.63308.21318.96290.6447.49479.93
Total Assets22,204.6419,017.2619,966.5716,836.6415,893.0613,735.1811,510.9611,052.548,666.926,945.85
Contingent Liabilities120.26152.93770.12,006.562,496.371,214.54427.41799.8558.92231.1

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...2,612.5
Depreciation1,244.58
Interest (Net)-16.95
P/L on Sales of Assets-13.23
Prov. and W/O (Net)69.08
P/L in Forex310.46
Total Adjustments (PBT and Ext...1,586.47
Operating Profit before Workin...4,198.97
Trade and 0ther Receivables-432.11
Inventories-926.7
Trade Payables707.65
Loans and Advances1.04
Total Adjustments (OP before W...-1,094.98
Cash Generated from/(used in) ...3,103.99
Direct Taxes Paid-717.24
Total Adjustments(Cash Generat...-717.24
Cash Flow before Extraordinary...2,386.75
Net Cash from Operating Activi...2,386.75
Purchased of Fixed Assets-2,720.4
Sale of Fixed Assets11.09
Purchase of Investments-2,014.1
Sale of Investments2,456.85
Interest Received146.62
Acquisition of Companies-28.05
Net Cash used in Investing Act...-3,977.81
Proceed from 0ther Long Term B...393.58
Proceed from Short Tem Borrowi...2,069.68
Of the Long Tem Borrowings-5.65
Of Financial Liabilities-92.47
Dividend Paid-439.53
Interest Paid-111.2
Net Cash used in Financing Act...1,814.41
Net Profit before Tax and Extr...1,614.35
Depreciation435.35
Interest (Net)-72.64
Dividend Received164.87
P/L on Sales of Assets-13.35
Prov. and W/O (Net)13.47
P/L in Forex-13.99
Total Adjustments (PBT and Ext...175.19
Operating Profit before Workin...1,789.54
Trade and 0ther Receivables-536.6
Inventories-739.9
Trade Payables78.89
Loans and Advances1.05
Total Adjustments (OP before W...332.21
Cash Generated from/(used in) ...2,121.75
Direct Taxes Paid-300.59
Total Adjustments(Cash Generat...-300.59
Cash Flow before Extraordinary...1,821.16
Net Cash from Operating Activi...1,821.16
Purchased of Fixed Assets-358.29
Sale of Fixed Assets23.22
Purchase of Investments-939.1
Interest Received79.71
Net Cash used in Investing Act...-3,459.2
Proceed from Short Tem Borrowi...2,287.31
Of Financial Liabilities-20.96
Dividend Paid-439.53
Interest Paid-107.34
Net Cash used in Financing Act...1,719.48

Company Details

Registered Office
AddressPlot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet
CityHyderabad
StateTelangana
Pin Code500038
Tel. No.91-40-23736370
Fax. No.91-40-23747340
Emailcs@aurobindo.com; investorgrievances@aurobindo.com
Internethttp://www.aurobindo.com
Registrars
AddressPlot No 2 Maitrivihar
CityHyderabad
StateTelangana
Pin Code500038
Tel. No.91-40-23736370
Fax. No.91-40-23747340
Emailcs@aurobindo.com; investorgrievances@aurobindo.com
Internethttp://www.aurobindo.com
Management
Name Designation
K RagunathanChairman & Independent Directo
Kambam Nityananda ReddyExecutive Director
M SivakumaranExecutive Director
M Madan Mohan ReddyExecutive Director
P V Ramprasad ReddyNon Executive Director
Savita MahajanIndependent Non Exe. Director
Girish Paman VanvariIndependent Non Exe. Director
P Sarath Chandra ReddyIndependent Non Exe. Director
Santanu MukherjeeIndependent Director
Deepali Pant JoshiAdditional Director